Do interventions to improve adherence to antiretroviral therapy recognise diversity? A systematic review

References

• Alsan, M., Beshears, J., Armstrong, W. S., Choi, J. J., Madrian, B. C., Nguyen, M. L. T., Del Rio, C., Laibson, D., & Marconi, V. C. (2017). A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. Aids (London, England), 31(12), 1765–1769. https://doi.org/10.1097/QAD.0000000000001543
   PubMed Web of Science ®Google Scholar
• Altice, F. L., Maru, D. S.-R., Bruce, R. D., Springer, S. A., & Friedland, G. H. (2007). Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clinical Infectious Diseases, 45(6), 770–778. https://doi.org/10.1086/521166
   PubMed Web of Science ®Google Scholar
• Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., Springer, S. A., & Friedland, G. H. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38(Suppl 5), S376–S387. https://doi.org/10.1086/421400
   PubMed Web of Science ®Google Scholar
• Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., Monforte, A. D., Wu, A. W., & Antinori, A. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. JAIDS Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S123–S127. https://doi.org/10.1097/00126334-200212153-00007
   PubMed Web of Science ®Google Scholar
• Andrade, A. S., McGruder, H. F., Wu, A. W., Celano, S. A., Skolasky, R. L. Jr., Selnes, O. A., Huang, I. C., & McArthur, J. C. (2005). A Programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clinical Infectious Diseases, 41(6), 875–882. https://doi.org/10.1086/432877
   PubMed Web of Science ®Google Scholar
• Antoni, M. H., Carrico, A. W., Durán, R. E., Spitzer, S., Penedo, F., Ironson, G., Fletcher, M. A., Klimas, N., & Schneiderman, N. (2006). Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosomatic Medicine, 68(1), 143–151. https://doi.org/10.1097/01.psy.0000195749.60049.63
   PubMed Web of Science ®Google Scholar
• Arribas, J. R., DeJesus, E., van Lunzen, J., Zurawski, C., Doroana, M., Towner, W., Lazzarin, A., Nelson, M., McColl, D., Andreatta, K., Swamy, R., Szwarcberg, J., & Nguyen, T. (2017). Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-PI. HIV Clinical Trials, 18(3), 118–125. https://doi.org/10.1080/15284336.2017.1330440
   PubMed Web of Science ®Google Scholar
• Bate, P., & Robert, G. (2006). Experience-based design: From redesigning the system around the patient to co-designing services with the patient. Quality and Safety in Health Care, 15(5), 307–310. https://doi.org/10.1136/qshc.2005.016527
   PubMed Web of Science ®Google Scholar
• Berg, K. M., Litwin, A., Li, X., Heo, M., & Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113(2), 192–199. https://doi.org/10.1016/j.drugalcdep.2010.07.025
   PubMed Web of Science ®Google Scholar
• Brett, J., Staniszewska, S., Mockford, C., Herron-Marx, S., Hughes, J., Tysall, C., & Suleman, R. (2014). A systematic review of the impact of patient and public involvement on service users, researchers and communities. The Patient - Patient-Centered Outcomes Research, 7(4), 387–395. https://doi.org/10.1007/s40271-014-0065-0
   Web of Science ®Google Scholar
• Brunetta, J., Moreno Guillén, S., Antinori, A., Yeni, P., Wade, B., Johnson, M., Shalit, P., Ebrahimi, R., Johnson, B., Walker, I., & De-Oertel, S. (2015). Patient-reported outcomes after a switch to a single-tablet regimen of rilpivirine, emtricitabine, and tenofovir DF in HIV-1-positive, virologically suppressed individuals: Additional findings from a randomized, open-label, 48-week trial. The Patient - Patient-Centered Outcomes Research, 8(3), 257–267. https://doi.org/10.1007/s40271-015-0123-2
   Web of Science ®Google Scholar
• Calderón, M. M., Penzak, S. R., Pau, A. K., Kumar, P., McManus, M., Alfaro, R. M., & Kovacs, J. A. (2016). Efavirenz but not atazanavir/ritonavir significantly reduces atovaquone concentrations in HIV-infected subjects. Clinical Infectious Diseases, 62(8), 1036–1042. https://doi.org/10.1093/cid/ciw028
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2017). HIV surveillance report, 2016; vol. 28. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Collier, A. C., Ribaudo, H., Mukherjee, A. L., Feinberg, J., Fischl, M. A., Chesney, M., & Adult, A. C. T. G. S. T. (2005). A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. The Journal of Infectious Diseases, 192(8), 1398–1406. https://doi.org/10.1086/466526
   PubMed Web of Science ®Google Scholar
• Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008). Developing and evaluating complex interventions: The new medical research council guidance. BMJ, 337. Article a1655.https://doi.org/10.1136/bmj.a1655.
   Google Scholar
• Croome, N., Ahluwalia, M., Hughes, L. D., & Abas, M. (2017). Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa. Aids (London, England), 31(7), 995–1007. https://doi.org/10.1097/qad.0000000000001416
   PubMed Web of Science ®Google Scholar
• Dale, S. K., Traeger, L., O'Cleirigh, C., Bedoya, C. A., Pinkston, M., Wilner, J. G., Stein, M., & Safren, S. A. (2016). Baseline substance use interferes with maintenance of HIV medication adherence skills. AIDS Patient Care and STDs, 30(5), 215–220. https://doi.org/10.1089/apc.2015.0340
   PubMed Web of Science ®Google Scholar
• de Bruin, M., Hospers, H. J., van Breukelen, G. J., Kok, G., Koevoets, W. M., & Prins, J. M. (2010). Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: A randomized controlled trial. Health Psychology, 29(4), 421–428. https://doi.org/10.1037/a0020335
   PubMed Web of Science ®Google Scholar
• DeVault, M. L., & Gross, G. (2012). Feminist interviewing: Experience, talk, and knowledge in Hesse-Biber, S. N. In Hesse-BiberS.N. (Ed.), Handbook of feminist research: Theory and praxis (2nd ed, pp. 173–197). SAGE Publications.
   Google Scholar
• DiIorio, C., Resnicow, K., McDonnell, M., Soet, J., McCarty, F., & Yeager, K. (2003). Using motivational interviewing to promote adherence to antiretroviral medications: A pilot study. Journal of the Association of Nurses in AIDS Care, 14(2), 52–62. https://doi.org/10.1177/1055329002250996
   PubMedGoogle Scholar
• Dilorio, C., McCarty, F., Resnicow, K., McDonnell Holstad, M., Soet, J., Yeager, K., Sharma, S. M., Morisky, D. E., & Lundberg, B. (2008). Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study. AIDS Care, 20(3), 273–283. https://doi.org/10.1080/09540120701593489.
   PubMed Web of Science ®Google Scholar
• Doerfler, R. E., & Goodfellow, L. (2016). Brief Exposure to cognitive behavioral therapy reduces side-effect symptoms in patients on antiretroviral therapy. Journal of the Association of Nurses in AIDS Care, 27(4), 455–467. https://doi.org/10.1016/j.jana.2016.02.010
   PubMed Web of Science ®Google Scholar
• Duncan, L. G., Moskowitz, J. T., Neilands, T. B., Dilworth, S. E., Hecht, F. M., & Johnson, M. O. (2012). Mindfulness-based stress reduction for HIV treatment side effects: A randomized, wait-list controlled trial. Journal of Pain and Symptom Management, 43(2), 161–171. https://doi.org/10.1016/j.jpainsymman.2011.04.007
   PubMed Web of Science ®Google Scholar
• Enriquez, M., Cheng, A.-L., Banderas, J., Farnan, R., Chertoff, K., Hayes, D., Ortego, G., Moreno, J., Peterson, J., & McKinsey, D. (2015). A peer-led HIV medication adherence intervention targeting adults linked to medical care but without a suppressed viral load. Journal of the International Association of Providers of AIDS Care, 14(5), 441–448. https://doi.org/10.1177/2325957414558301
   PubMedGoogle Scholar
• Floris-Moore, M. A., Mollan, K., Wilkin, A. M., Johnson, M. A., Kashuba, A. D., Wohl, D. A., Patterson, K. B., Francis, O., Kronk, C., & Eron, J. J. (2016). Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antiviral Therapy, 21(1), 55–64. doi:http://doi.org/10.3851/IMP2982%29
   PubMed Web of Science ®Google Scholar
• Garland, W. H., Wohl, A. R., Valencia, R., Witt, M. D., Squires, K., Kovacs, A., Larsen, R., Potterat, N., Anthony, M.-N., Hader, S., & Weidle, P. J. (2007). The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California. AIDS Care, 19(2), 159–167. https://doi.org/10.1080/09540120600911428
   PubMed Web of Science ®Google Scholar
• Gibbs, L., Gold, L. C., Kulkens, M., Riggs, E., Van Gemert, C., & Waters, E. (2008). Are the potential benefits of a community-based participatory approach to public health research worth the potential cost? Just Policy: A Journal of Australian Social Policy, 47, 54–59.
   Google Scholar
• Gibbs, L.,, Waters, E., Renzaho, A., & Kulkens, M. (2007). Moving towards increased cultural competency in public health research. In D. R. Williamson A (Ed.), Researching with communities: Grounded perspectives on engaging communities in research (pp. 339–355). Muddy Creek Press.
   Google Scholar
• Goggin, K., Gerkovich, M. M., Williams, K. B., Banderas, J. W., Catley, D., Berkley-Patton, J., Wagner, G. J., Stanford, J., Neville, S., Kumar, V. K., Bamberger, D. M., & Clough, L. A. (2013). A Randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence. AIDS and Behavior, 17(6), 1992–2001. https://doi.org/10.1007/s10461-013-0467-3
   PubMed Web of Science ®Google Scholar
• Golin, C. E., Knight, K., Carda-Auten, J., Gould, M., Groves, J., L.White, B., Bradley-Bull, S., Amola, K., Fray, N., Rosen, D. L., Mugavaro, M. J., Pence, B. W., Flynn, P. M., & Wohl, D. (2016). Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care. BMC Public Health, 16(1), 935. https://doi.org/10.1186/s12889-016-3511-1
   PubMedGoogle Scholar
• Goujard, C., Bernard, N., Sohier, N., Peyramond, D., Lancon, F., Chwalow, J., Arnould, B., & Delfraissy, J. F. (2003). Impact of a patient education program on adherence to HIV medication. JAIDS Journal of Acquired Immune Deficiency Syndromes, 34(2), 191–194. https://doi.org/10.1097/00126334-200310010-00009
   PubMed Web of Science ®Google Scholar
• Gross, R., Bellamy, S. L., Chapman, J., Han, X., O’Duor, J., Palmer, S. C., Houts, P. S., Coyne, J. C., & Strom, B. L. (2013). Managed problem solving for antiretroviral therapy adherence. JAMA Internal Medicine, 173(4), 300–306. https://doi.org/10.1001/jamainternmed.2013.2152
   PubMed Web of Science ®Google Scholar
• Gross, R., Tierney, C., Andrade, A., Lalama, C., Rosenkranz, S., Eshleman, S. H., Flanigan, T, Santana, J, Salomon, N, Reiser, R, Wiggins, I, Hogg, E, Flexner, C, & Mildvan, D. (2009). Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: A randomized trial. Archives of Internal Medicine, 169(13), 1224–1232. https://doi.org/10.1001/archinternmed.2009.172.
   PubMed Web of Science ®Google Scholar
• Gwadz, M., Cleland, C. M., Applegate, E., Belkin, M., Gandhi, M., Salomon, N., Banfield, A., Leonard, N., Riedel, M., Wolfe, H., Pickens, I., Bolger, K., Bowens, D., Perlman, D., Mildvan, D., & The Heart to Heart Collaborative Research Team. (2015). Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: A randomized controlled trial of a novel intervention. AIDS and Behavior, 19(10), 1801–1817. https://doi.org/10.1007/s10461-015-1054-6
   PubMed Web of Science ®Google Scholar
• Hernando, V., Alvárez-del Arco, D., Alejos, B., Monge, S., Amato-Gauci, A. J., Noori, T., Pharris, A., & del Amo, J. (2015). HIV infection in migrant populations in the European Union and European Economic area in 2007–2012. JAIDS Journal of Acquired Immune Deficiency Syndromes, 70(2), 204–211. https://doi.org/10.1097/qai.0000000000000717
   PubMed Web of Science ®Google Scholar
• Hersch, R. K., Cook, R. F., Billings, D. W., Kaplan, S., Murray, D., Safren, S., Goforth, J., & Spencer, J. (2013). Test of a web-based program to improve adherence to HIV medications. AIDS and Behavior, 17(9), 2963–2976. https://doi.org/10.1007/s10461-013-0535-8
   PubMed Web of Science ®Google Scholar
• Himelhoch, S., Kreyenbuhl, J., Palmer-Bacon, J., Chu, M., Brown, C., & Potts, W. (2017). Pilot feasibility study of Heart2HAART: A smartphone application to assist with adherence among substance users living with HIV. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 29(7), 898–904. https://doi.org/10.1080/09540121.2016.1259454
   PubMed Web of Science ®Google Scholar
• Holstad, M. M., DiIorio, C., Kelley, M. E., Resnicow, K., & Sharma, S. (2011). Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS and Behavior, 15(5), 885–896. https://doi.org/10.1007/s10461-010-9865-y
   PubMed Web of Science ®Google Scholar
• Holzemer, W. L., Bakken, S., Portillo, C. J., Grimes, R., Welch, J., Wantland, D., & Mullan, J. T. (2006). Testing a nurse-tailored HIV medication adherence intervention. Nursing Research, 55(3), 189–197. https://doi.org/10.1097/00006199-200605000-00005
   PubMed Web of Science ®Google Scholar
• Hughson, J.-a., Woodward-Kron, R., Parker, A., Hajek, J., Bresin, A., Knoch, U., Phan, T., & Story, D. (2016). A review of approaches to improve participation of culturally and linguistically diverse populations in clinical trials. Trials, 17(1), 263. https://doi.org/10.1186/s13063-016-1384-3
   PubMed Web of Science ®Google Scholar
• Huhn, G. D., Sigman, A., & Livak, B. (2015). Simplification from twice-daily to once-daily darunavir/ritonavir in a randomized trial among HIV-infected persons with HIV-1 RNA suppression on antiretroviral therapy. Antiviral Therapy, 20(8), 849–854. doi:https://doi.org/10.3851/IMP2962
   PubMed Web of Science ®Google Scholar
• Huhn, G. D., Tebas, P., Gallant, J., Wilkin, T., Cheng, A., Yan, M., Zhong, L., Callebaut, C., Custodio, J. M., Fordyce, M. W., Das, M., & McCallister, S. (2017). A randomized, open-label trial to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide plus darunavir in treatment-experienced HIV-1-infected adults. JAIDS Journal of Acquired Immune Deficiency Syndromes, 74(2), 193–200. doi:https://doi.org/10.1097/QAI.0000000000001193
   PubMed Web of Science ®Google Scholar
• Hunt, L. M., & de Voogd, K. B. (2007). Are good intentions good enough?: Informed consent without trained interpreters. Journal of General Internal Medicine, 22(5), 598. https://doi.org/10.1007/s11606-007-0136-1
   PubMed Web of Science ®Google Scholar
• Ingersoll, K. S., Dillingham, R. A., Hettema, J. E., Conaway, M., Freeman, J., Reynolds, G., & Hosseinbor, S. (2015). Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. Health Psychology, 34S(Suppl), 1305–1315. doi:https://doi.org/10.1037/hea0000295
   PubMedGoogle Scholar
• Ingersoll, K. S., Dillingham, R., Reynolds, G., Hettema, J., Freeman, J., Hosseinbor, S., & Winstead-Derlega, C. (2014). Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers. Journal of Substance Abuse Treatment, 46(1), 66–73. https://doi.org/10.1016/j.jsat.2013.08.002
   PubMed Web of Science ®Google Scholar
• Ingersoll, K. S., Farrell-Carnahan, L., Cohen-Filipic, J., Heckman, C. J., Ceperich, S. D., Hettema, J., & Marzani-Nissen, G. (2011). A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug and Alcohol Dependence, 116(1), 177–187. doi:https://doi.org/10.1016/j.drugalcdep.2010.12.016
   PubMed Web of Science ®Google Scholar
• Javanbakht, M., Prosser, P., Grimes, T., Weinstein, M., & Farthing, C. (2006). Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients. Journal of the International Association of Physicians in AIDS Care, 5(4), 143–150. https://doi.org/10.1177/1545109706291706
   Google Scholar
• Johnson, M. O., Charlebois, E., Morin, S. F., Remien, R. H., Chesney, M. A., & the National Institute of Mental Health Healthy Living Project Team. (2007). Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(5), 574–580. https://doi.org/10.1097/QAI.0b013e318158a474
   PubMed Web of Science ®Google Scholar
• Johnson, M. O., Dilworth, S. E., Taylor, J. M., & Neilands, T. B. (2011). Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Annals of Behavioral Medicine, 41(1), 83–91. https://doi.org/10.1007/s12160-010-9230-4
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Cherry, C., Kalichman, M. O., Amaral, C. M., White, D., Pope, H., Swetzes, C., Eaton, L., Macy, R., & Cain, D. (2011). Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. American Journal of Public Health, 101(3), 531–538. https://doi.org/10.2105/ajph.2010.197608
   PubMed Web of Science ®Google Scholar
• Kanters, S., Park, J. J. H., Chan, K., Socias, M. E., Ford, N., Forrest, J. I., Thorlund, K., Nachega, J. B., & Mills, E. J. (2017). Interventions to improve adherence to antiretroviral therapy: A systematic review and network meta-analysis. The Lancet HIV, 4(1), Article e31–e40. https://doi.org/10.1016/S2352-3018(16)30206-5
   Web of Science ®Google Scholar
• Konkle-Parker Deborah, J., Erlen Judith, A., Dubbert Patricia, M., & May, W. (2012). Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South. Journal of the American Academy of Nurse Practitioners, 24(8), 488–498. https://doi.org/10.1111/j.1745-7599.2012.00712.x
   PubMedGoogle Scholar
• Kurth, A. E., Spielberg, F., Cleland, C. M., Lambdin, B., Bangsberg, D. R., Frick, P. A., Severynen, A. O., Clausen, M., Norman, R. G., Lockhart, D., Simoni, J. M., & Holmes, K. K. (2014). Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(5), 611–620. https://doi.org/10.1097/QAI.0000000000000100
   PubMed Web of Science ®Google Scholar
• Levin, T. R., Klibanov, O. M., Axelrod, P., van der Berg-Wolf, M., Finley, G. L., Gray, A., Holdsworth, C., Moyer, D. V., Tedaldi, E. M., & Samuel, R. (2006). A randomized trial of educational materials, pillboxes, and mailings to improve adherence with antiretroviral therapy [Q36]in an Inner City HIV clinic, 13(4.
   Google Scholar
• Lucas, G. M., Mullen, B. A., Galai, N., Moore, R. D., Cook, K., McCaul, M. E., Glass, S., Oursler, K. K., Rand, C., & Braitstein, P. (2013). Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial. PLoS ONE, 8(7), 1–10. https://doi.org/10.1371/journal.pone.0068286
   Web of Science ®Google Scholar
• Macalino, G. E., Hogan, J. W., Mitty, J. A., Bazerman, L. B., DeLong, A. K., Loewenthal, H., Caliendo, A. M., & Flanigan, T. P. (2007). A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. Aids (London, England), 21(11), 1473–1477. https://doi.org/10.1097/QAD.0b013e32811ebf68
   PubMed Web of Science ®Google Scholar
• Macalino, G. E., Mitty, J. A., Bazerman, L. B., Singh, K., McKenzie, M., & Flanigan, T. (2004). Modified directly observed therapy for the treatment of HIV-seropositive substance users: Lessons learned from a pilot study. Clinical Infectious Diseases, 38(Suppl 5), S393–S397. https://doi.org/10.1086/421402
   PubMed Web of Science ®Google Scholar
• Magidson, J. F., Blashill, A. J., Safren, S. A., & Wagner, G. J. (2015). Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: A longitudinal mediation analysis. AIDS & Behavior, 19(1), 34–40. https://doi.org/10.1007/s10461-014-0802-3
   PubMed Web of Science ®Google Scholar
• Mannheimer, S. B., Morse, E., Matts, J. P., Andrews, L., Child, C., Schmetter, B., & Friedland, G. H. (2006). Sustained benefit from a long-term antiretroviral adherence intervention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(Supplement(1)), S41–S47. https://doi.org/10.1097/01.qai.0000245887.58886.ac
   PubMedGoogle Scholar
• Maru, D. S., Bruce, R. D., Walton, M., Springer, S. A., & Altice, F. L. (2009). Persistence of virological benefits following directly administered antiretroviral therapy among drug users: Results from a randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(2), 176–181. https://doi.org/10.1097/QAI.0b013e3181938e7e
   PubMed Web of Science ®Google Scholar
• Miro, J. M., Manzardo, C., Ferrer, E., Loncà, M., Guardo, A. C., Podzamczer, D., Domingo, P., Curran, A., Clotet, B., Cruceta, A., Lozano, F., Pérez, I., Plana, M., & Gatell, J. M. (2015). Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV-1-infected patients starting efavirenz, lopinavir-ritonavir, or atazanavir-ritonavir plus tenofovir/emtricitabine: Final 48-week results (The Advanz-3 trial). Journal of Acquired Immune Deficiency Syndromes, 69(2), 206–215. https://doi.org/10.1097/QAI.0000000000000567
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., Liberati, A., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. British Medical Journal, 339, 332–336. https://doi.org/10.1136/bmj.b2535.
   Web of Science ®Google Scholar
• Moore, D. J., Montoya, J. L., Blackstone, K., Rooney, A., Gouaux, B., Georges, S., Depp, C. A., Atkinson, J. H., & the TMARC Group. (2013). Preliminary evidence for feasibility, use, and acceptability of individualized texting for adherence building for antiretroviral adherence and substance use assessment among HIV-infected methamphetamine users. AIDS Research and Treatment, 2013, Article 585143. https://doi.org/10.1155/2013/585143
   PubMedGoogle Scholar
• Moore, D. J., Poquette, A., Casaletto, K. B., Gouaux, B., Montoya, J. L., Posada, C., Rooney, A. S., Badiee, J., Deutsch, R., Letendre, S. L., Depp, C. A., Grant, I., Hampton Atkinson, J., & The HIV Neurobehavioral Research Program (HNRP) Group. (2015). Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS and Behavior, 19(3), 459–471. https://doi.org/10.1007/s10461-014-0971-0
   PubMed Web of Science ®Google Scholar
• Murphy, D. A., Marelich, W. D., Rappaport, N. B., Hoffman, D., & Farthing, C. (2007). Results of an antiretroviral adherence intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). Journal of the International Association of Physicians in AIDS Care, 6(2), 113–124. https://doi.org/10.1177/1545109707301243
   Google Scholar
• National Quality Forum. (2008). Endorsing a framework and preferred practices for measuring and reporting culturally competent care quality.
   Google Scholar
• Nnaji, C., Boone, M., Pugnaire, M. P., Goode, T., Wellman, S., Gunn, A. R., Jenkins, B., McNickles, J., Gardiner, B., Jerry, M., Santos, M., Powell, L., Person, S., & Allison, J. (2018). An innovative simulation-based community-engaged intervention for training research assistants in culturally appropriate informed consent. Progress in Community Health Partnerships: Research, Education, and Action, 12(3), 247–262. https://doi.org/10.1353/cpr.2018.0049
   PubMedGoogle Scholar
• Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(4), 443–450. https://doi.org/10.1097/QAI.0b013e318158a461
   PubMed Web of Science ®Google Scholar
• Pellowski, J. A., Kalichman, S. C., & Grebler, T. (2016). Optimal treatment adherence counseling outcomes for people living with HIV and limited health literacy. Behavioral Medicine, 42(1), 39–47. https://doi.org/10.1080/08964289.2014.963006
   PubMed Web of Science ®Google Scholar
• Pence, B. W., Gaynes, B. N., Adams, J. L., Thielman, N. M., Heine, A. D., Mugavero, M. J., McGuinness, T., Raper, J. L., Willig, J. H., Shirey, K. G., Ogle, M., Turner, E. L., & Byrd Quinlivan, E. (2015). The effect of antidepressant treatment on HIV and depression outcomes: Results from a randomized trial. Aids (London, England), 29(15), 1975–1986. https://doi.org/10.1097/QAD.0000000000000797
   PubMed Web of Science ®Google Scholar
• Perez-Molina, J. A., Rubio, R., Rivero, A., Pasquau, J., Suárez-Lozano, I., Riera, M., Estébanez, M., Santos, J., Sanz-Moreno, J., Troya, J., Mariño, A., Antela, A., Navarro, J., Esteban, H., & Moreno, S. (2015). Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial. The Lancet Infectious Diseases, 15(7), 775–784. https://doi.org/10.1016/s1473-3099(15)00097-3
   PubMed Web of Science ®Google Scholar
• Pradier, C., Bentz, L., Spire, B., Tourette-Turgis, C., Morin, M., Souville, M., Rebillon, M., Fuxibet, J.-G., Pesce, A, Dellamonica, P, & Moatti, J.-P. (2003). Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clinical Trials, 4(2), 121–131. https://doi.org/10.1310/hct.2003.4.2.007.
   PubMed Web of Science ®Google Scholar
• Prosser, A. T., Tang, T., & Hall, H. I. (2012). HIV in persons born outside the United States, 2007-2010. Jama, 308(6), 601–607. https://doi.org/10.1001/jama.2012.9046
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia, P., & Côté, J. (2012). An individualized intervention to foster optimal antiretroviral treatment-taking behavior among persons living with HIV: A pilot randomized controlled trial. Journal of the Association of Nurses in AIDS Care, 23(3), 220–232. https://doi.org/10.1016/j.jana.2011.04.003
   PubMed Web of Science ®Google Scholar
• Rathbun, C., Farmer, K. C., Stephens, J. R., & Lockhart, S. M. (2005). Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: A prospective, randomized, controlled pilot study. Clinical Therapeutics, 27(2), 199–209. https://doi.org/10.1016/j.clinthera.2005.02.010
   PubMed Web of Science ®Google Scholar
• Rawlings, M. K., Thompson, M. A., Farthing, C. F., Brown, L. S., Racine, J., Scott, R. C., Crawford, K. H., Goodwin, S. D., Tolson, J. M., Williams, V. C., & Shaefer, M. S. (2003). Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/Abacavir regimen in underrepresented HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 34(2), 174–183. https://doi.org/10.1097/00126334-200310010-00007
   PubMed Web of Science ®Google Scholar
• Remien, R. H., Stirratt, M. J., Dolezal, C., Dognin, J. S., Wagner, G. J., Carballo-Dieguez, A., El-Bassel, N., & Jung, T. M. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. Aids (London, England), 19(8), 807–814. https://doi.org/10.1097/01.aids.0000168975.44219.45
   PubMed Web of Science ®Google Scholar
• Reynolds, N. R., Testa, M. A., Su, M., Chesney, M. A., Neidig, J. L., Frank, I., Smith, S., Ickovics, J., & Robbins, G. K. (2008). Telephone support to improve antiretroviral medication adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(1), 62–68. https://doi.org/10.1097/QAI.0b013e3181582d54
   PubMed Web of Science ®Google Scholar
• Riggs, E., Gussy, M., Gibbs, L., van Gemert, C., Waters, E., Priest, N., Watt, R., Renzaho, A. M. N., & Kilpatrick, N. (2014). Assessing the cultural competence of oral health research conducted with migrant children. Community Dentistry and Oral Epidemiology, 42(1), 43–52. https://doi.org/10.1111/cdoe.12058
   PubMed Web of Science ®Google Scholar
• Robbins, G. K., Cohn, S. E., Harrison, L. J., Smeaton, L., Moran, L., Rusin, D., Dehlinger, M., Flynn, T., Lammert, S., Wu, A. W., Safren, S. A., & Reynolds, N. R. (2016). Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: A post hoc analysis of ACTG 5251. HIV Clinical Trials, 17(4), 165–172. https://doi.org/10.1080/15284336.2016.1189754
   PubMed Web of Science ®Google Scholar
• Robbins, G. K., Testa, M. A., Su, M., Safren, S. A., Morse, G., Lammert, S., Shafer, R. W., Reynolds, N. R., & Chesney, M. A. (2013). Site nurse–initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: Substudy of ACTG 384. HIV Clinical Trials, 14(5), 235–253. https://doi.org/10.1310/hct1405-235
   PubMed Web of Science ®Google Scholar
• Rosen, M. I., Dieckhaus, K., McMahon, T. J., Valdes, B., Petry, N. M., Cramer, J., & Rounsaville, B. (2007). Improved adherence with contingency management. AIDS Patient Care and STDs, 21(1), 30–40. https://doi.org/10.1089/apc.2006.0028
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Holmes, A. M., Stump, T. E., Aalsma, M. C., Ackermann, R. T., Carney, T. S., Katz, B. P., Kesterson, J., Erdman, S. M., Balt, C. A., & Inui, T. S. (2012). Can lay health workers promote better medical self-management by persons living with HIV? An evaluation of the Positive Choices program. Patient Education and Counseling, 89(1), 184–190. https://doi.org/10.1016/j.pec.2012.06.010
   PubMed Web of Science ®Google Scholar
• Safren, A., Andres Bedoya, C., O'Cleirigh, C., Biello, K. B., Pinkston, M. M., Stein, M. D., Traeger, L., Kojic, E., Robbins, G. K., Lerner, J. A., Herman, D. S., Mimiaga, M. J., & Mayer, K. H. (2016). Cognitive behavioural therapy for adherence and depression in patients with HIV: A three-arm randomised controlled trial. The Lancet. HIV, 3(11), Article e529–e538. https://doi.org/10.1016/S2352-3018(16)30053-4
   PubMed Web of Science ®Google Scholar
• Safren, S. A., Hendriksen, E. S., Desousa, N., Boswell, S. L., & Mayer, K. H. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15(6), 787–793. https://doi.org/10.1080/09540120310001618630
   PubMed Web of Science ®Google Scholar
• Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80(3), 404–415. https://doi.org/10.1037/a0028208
   PubMed Web of Science ®Google Scholar
• Safren, S. A., Otto, M., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-Steps and medication monitoring. Behaviour Research and Therapy, 39(10), 1151–1162. https://doi.org/10.1016/S0005-7967(00)00091-7
   PubMed Web of Science ®Google Scholar
• Samet, J. H., Horton, N. J., Meli, S., Dukes, K., Tripps, T., Sullivan, L., & Freedberg, K. A. (2005). A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antiviral Therapy, 10(1), 83–93.
   PubMed Web of Science ®Google Scholar
• Schafer, J. J., Naples, J. G., Pizzi, L. T., & Desimone, J. A. (2015). The effects of a pharmacist-delivered patient education programme on retention in human immunodeficiency virus care: A pilot study. Journal of Pharmaceutical Health Services Research, 6(2), 83–89. https://doi.org/10.1111/jphs.12092
   Web of Science ®Google Scholar
• Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology, 63(8). https://doi.org/10.1016/j.jclinepi.2010.02.005
   Web of Science ®Google Scholar
• Shippee, N. D., Domecq Garces, J. P., Prutsky Lopez, G. J., Wang, Z., Elraiyah, T. A., Nabhan, M., Brito, J. P., Boehmer, K., Hasan, R., Firwana, B., Erwin, P. J., Montori, V. M., & Murad, M. H. (2015). Patient and service user engagement in research: A systematic review and synthesized framework. Health Expectations, 18(5), 1151–1166. https://doi.org/10.1111/hex.12090
   PubMed Web of Science ®Google Scholar
• Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., & Ford, N. (2016). Patient-reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Medicine, 13(11), Article e1002183. https://doi.org/10.1371/journal.pmed.1002183
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Aunon, F. M., Kemp, C. G., Kutner, B. A., Ramaiya, M. K., Velloza, J., & Yang, J. P. (2017). Implementation research on HIV adherence interventions: No time to wait. The Lancet Infectious Diseases, 17(6), 564–565. https://doi.org/10.1016/S1473-3099(17)30106-8
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Huh, D. M. S., Frick, P. A., Pearson, C. R., Andrasik, M. P., Dunbar, P. J., & Hooton, T. M. (2009). Peer support and pager messaging to promote antiretroviral modifying therapy in seattle: A randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52(4), 465–473. https://doi.org/10.1097/QAI.0b013e3181b9300c
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Pantalone, D. W., Plummer, M. D., & Huang, B. (2007). A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychology, 26(4), 488–495. https://doi.org/10.1037/0278-6133.26.4.488
   PubMed Web of Science ®Google Scholar
• Slama, L., Landman, R., Assoumou, L., Benalycherif, A., Samri, A., Joly, V., Pialoux, G., Valin, N., Cabié, A., Duvivier, C., Lambert-Niclot, S., Marcelin, A.-G., Peytavin, G., Costagliola, D., & Girard, P.-M. (2016). Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: A 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial). Journal of Antimicrobial Chemotherapy, 71(8), 2252–2261. doi:http://doi.org/10.1093/jac/dkw103
   PubMed Web of Science ®Google Scholar
• Smith, S. R., Rublein, J. C., Marcus, C., Brock, T. P., & Chesney, M. A. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling, 50(2), 187–199. https://doi.org/10.1016/S0738-3991(02)00127-1
   PubMed Web of Science ®Google Scholar
• Staniszewska, S., Brett, J., Simera, I., Seers, K., Mockford, C., Goodlad, S., Altman, D. G., Moher, D., Barber, R., Denegri, S., Entwistle, A., Littlejohns, P., Morris, C., Suleman, R., Thomas, V., & Tysall, C. (2017). GRIPP2 reporting checklists: Tools to improve reporting of patient and public involvement in research. BMJ, 358, 3453. https://doi.org/10.1136/bmj.j3453
   PubMed Web of Science ®Google Scholar
• Tuldrà, A., Fumaz, C. R., Ferrer, M. J., Bayés, R., Arnó, A., Balagué, M., Bonjoch, A., Jou, A., Negredo, E., Paredes, R., Ruiz, L., Romeu, J., Sirera, G., Tural, C., Burger, D., & Clotet, B. (2000). Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 25(3), 221–228. https://doi.org/10.1097/00126334-200011010-00003
   PubMed Web of Science ®Google Scholar
• van Servellen, G., Carpio, F., Lopez, M., Garcia-Teague, L., Herrera, G., Monterrosa, F., Gomez, R., & Lombardi, E. (2003). Program to enhance health literacy and treatment adherence in low-income HIV-infected Latino men and women. AIDS Patient Care and STDs, 17(11), 581–594. https://doi.org/10.1089/108729103322555971
   PubMed Web of Science ®Google Scholar
• van Servellen, G., Nyamathi, A., Carpio, F., Pearce, D., Garcia-Teague, L., Herrera, G., & Lombardi, E. (2005). Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos. AIDS Patient Care and STDs, 19(11), 745–759. https://doi.org/10.1089/apc.2005.19.745
   PubMed Web of Science ®Google Scholar
• Wagner, G. J., Kanouse, D. E., Golinelli, D., Miller, L. G., Daar, E. S., Witt, M. D., Diamond, C., Tilles, J. G., Kemper, C. A., Larsen, R., Goicoechea, M., & Haubrich, R. H. (2006). Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: A randomized controlled trial (CCTG 578). Aids (London, England), 20(9), 1295–1302. https://doi.org/10.1097/01.aids.0000232238.28415.d2
   PubMed Web of Science ®Google Scholar
• Wagner, G. J., Lovely, P., & Schneider, S. (2013). Pilot controlled trial of the adherence readiness program: An intervention to assess and sustain HIV antiretroviral adherence readiness. AIDS and Behavior, 17(9), 3059–3065. https://doi.org/10.1007/s10461-013-0550-9
   PubMed Web of Science ®Google Scholar
• Weber, R., Christen, L., Christen, S., Tschopp, S., Znoj, H., Schneider, C., Schmitt, J., Opravil, M., Günthard, H. F., & Ledergerber, B. (2004). Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: Prospective randomized trial. Antiviral Therapy, 9(1), 85–95.
   PubMed Web of Science ®Google Scholar
• White, B. L., Golin, C. E., Grodensky, C. A., Nichole Kiziah, C., Richardson, A., Hudgens, M. G., Wohl, D. A., & Kaplan, A. H. (2015). Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: A randomized controlled pilot study. AIDS & Behavior, 19(1), 128–136. https://doi.org/10.1007/s10461-014-0850-8
   PubMed Web of Science ®Google Scholar
• Wilkins, E. L., Cohen, C. J., Trottier, B., Esser, S., Smith, D. E., Haas, B., Brinson, C., Garner, W., Chuck, S., Thorpe, D., & De-Oertel, S. (2016). Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment. AIDS Care, 28(3), 401–408. https://doi.org/10.1080/09540121.2015.1096890
   PubMed Web of Science ®Google Scholar
• Williams, A. B., Fennie, K. P., Bova, C. A., Burgess, J. D., Danvers, K. A., & Dieckhaus, K. D. (2006). Home visits to improve adherence to highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42(3), 314–321. https://doi.org/10.1097/01.qai.0000221681.60187.88
   PubMed Web of Science ®Google Scholar
• Wohl, D. A., Bhatti, L., Small, C. B., Edelstein, H., Zhao, H. H., Margolis, D. A., DeJesus, E., Weinberg, W. G., Ross, L. L., & Shaefer, M. S. (2016). The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to Abacavir/lamivudine+atazanavir. HIV Medicine, 17(2), 106–117. https://doi.org/10.1111/hiv.12281
   PubMed Web of Science ®Google Scholar
• Wohl, A. R., Garland, W. H., Squires, K., Witt, M., Larsen, R., Kovacs, A., & Weidle, P. J. (2004). The feasibility of a community-based directly administered antiretroviral therapy program. Clin Infect Dis, 38(5). https://doi.org/10.1086/421401.
   PubMedGoogle Scholar
• Wohl, A. R., Garland, W. H., Valencia, R., Squires, K., Witt, M. D., Kovacs, A., Larsen, R., Hader, S., Anthony, M.-N., & Weidle, P. J. (2006). A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clinical Infectious Diseases, 42(11), 1619–1627. https://doi.org/10.1086/503906
   PubMed Web of Science ®Google Scholar
• Wohl, D. A., Golin, C. E., Knight, K., Gould, M., Carda-Auten, J., Groves, J. S., Napravnik, S., Cole, S. R., White, B. L., Fogel, C., Rosen, D. L., Mugavaro, M. J., Pence, B. W., & Flynn, P. M. (2017). Randomized controlled trial of an intervention to maintain suppression of HIV viremia after prison release: The imPACT trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(1), 81–90. https://doi.org/10.1097/QAI.0000000000001337
   PubMed Web of Science ®Google Scholar